{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:28:52Z","timestamp":1788863332428,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejso.2015.04.013","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T02:31:38Z","timestamp":1431052298000},"page":"875-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1"],"prefix":"10.1016","volume":"41","author":[{"given":"H.","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-1795","authenticated-orcid":false,"given":"J.","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2015.04.013_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3949\/ccjm.27.2.82","article-title":"Intravenous infusion of dialyzed, autogenous, ascitic fluid in the management of cirrhotic ascites: a preliminary report of favorable results in six patients","volume":"27","author":"Britton","year":"1960","journal-title":"Cleve Clin Q"},{"key":"10.1016\/j.ejso.2015.04.013_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002480-197700230-00189","article-title":"Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid","volume":"23","author":"Inoue","year":"1977","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/j.ejso.2015.04.013_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine1962.30.311","article-title":"Prevention of the febrile reaction occurring on reinfusion of cell-free and concentrated autogenous ascites","volume":"30","author":"Katoh","year":"1991","journal-title":"Jpn J Med"},{"key":"10.1016\/j.ejso.2015.04.013_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10147-011-0199-1","article-title":"Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives","volume":"16","author":"Japanese","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2015.04.013_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000209277","article-title":"Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer","volume":"76","author":"Ishigami","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2015.04.013_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/annonc\/mdp260","article-title":"Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis","volume":"21","author":"Ishigami","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2015.04.013_bib7","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/cncr.28204","article-title":"A\u00a0phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis","volume":"119","author":"Yamaguchi","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.04.013_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-013-3208-y","article-title":"Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites","volume":"21","author":"Kitayama","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.04.013_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jjco\/hys129","article-title":"Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis","volume":"42","author":"Emoto","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2015.04.013_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1744-9987.12049","article-title":"Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites","volume":"18","author":"Ito","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ejso.2015.04.013_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9610(80)90241-X","article-title":"Complications after peritoneovenous shunting for ascites","volume":"139","author":"Greig","year":"1980","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2015.04.013_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2015.04.013_bib13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D'Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2015.04.013_bib14","article-title":"Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites","author":"Ito","year":"2014","journal-title":"Int J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315004151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315004151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T16:27:06Z","timestamp":1537633626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315004151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0748798315004151"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.04.013","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}